During his time with Covidien, Lannum oversaw the company’s initial public offering, which was the largest-ever in healthcare, and led the investor relations efforts for its merger with Medtronic (NYSE:MDT) in 2015, according to a press release.
Biehl was acting CEO of CxCTeams when he joined Imaging3, the company said, and also served as exec VP and CFO to several of its clients.
“Joe brings extensive C-level financial management experience working with companies at our stage of development, including the challenges that face rapidly growing companies, which we hope to test,” CEO John Hollister said in a prepared statement.
“I look forward to supporting Imaging3 during this critical phase of their re-emergence from the past few years,” Biehl said in a press release.
Ophthalmic medical device company Sight Sciences said last week it appointed Jesse Selnick as its chief financial officer.
Prior to joining Sight Sciences, Selnick served as CFO and a member of the board of directors at private equity sponsored telecom infrastructure biz Electric Lightwave before it was acquired for $1.4 billion in 2017. Selnick has served as a general partner of founding Sight Sciences investor Sight Sciences Angels since 2011, the company said.
“We are thrilled Jesse is joining Sight Sciences, as this is the perfect time in our corporate evolution to add someone with his strategic, financial and operational background. Jesse has a long and proven track record of operating and advising rapidly growing technology businesses to achieve scale and maximize value. Importantly, Jesse has been involved in our company’s early development as a founding investor and is very familiar with our business. Our tightly knit team and culture of community and trust is paramount to our success, and Jesse has seamlessly transitioned into his senior leadership role and is already making a substantial impact on our business, management team and board of directors,” CEO & prez Paul Badawi said in a press release.
“I am honored Paul asked me to join Sight Sciences in a full-time capacity. What Paul and his team have built is nothing short of extraordinary – developing category-defining products from an efficacy, ease of use and underlying product economics standpoint. I am excited to be part of the company’s growth phase. We are rapidly growing our operations and rate of financial investment to scale the business after recruiting our commercial leader, Shawn O’Neilfrom Alcon, and the recent FDA clearance of our Omni Surgical System. Further, we are preparing for next year’s exciting formal launch of our TearCare dry eye solution,” Selnik said in a prepared statement.
Cogmedix said last week it named David Fraser as its new operations senior VP, which the company said comes as part of an effort to broaden and strengthen its operational bandwidth.
Prior to joining Cogmedix, Fraser was employed by EMC, where he spent six years as manufacturing and worldwide materials VP, the Worcester, Mass.-based company said.
“David has an impressive professional background. He has been in the manufacturing field for over 30 years, holding several leadership roles in operations, planning and supply chain. He has a record of accomplishment in cost and cycle reductions, inventory efficiency, cross-functional team building, and mentoring future leaders. We are confident his skills will help take Cogmedix to new heights in operational excellence and scalable, profitable growth,” exec VP and GM Matt Giza said in a press release.
Cogmedix said that with the addition of Fraser, it will be looking to unify its manufacturing and supply chain under a single leader hoping to improve efficiency and customer satisfaction.
As part of the appointment, Varex said it consolidated its operations in China under Liang’s lead, including all sales and operational management and corporate functions including human resources, finance and quality and regulatory duties.
“I would like to welcome Liang to Varex Imaging. I believe his background and experience will be a tremendous asset to our organization and signal to the Chinese market and to our customers the significance and importance of our business in China for our future growth. The demand for X-ray imaging components, including CT, continues to grow and we see substantial opportunities for us to partner with OEMs to help them bring new imaging systems to market. Last year, we made good traction with some of the local Chinese OEMs and I expect that we will see a number of others become successful in bringing new systems using our components to market in the coming years,” prez & CEO Sunny Sanyal said in a prepared statement.